Reslizumab intravenous (IV) vs placeboHealth‐related quality of life (AQLQ)Scale from: 1‐7 (higher is better) · people with asthma1 finding from 1 reviewAnti‐IL‐5 therapies for asthma 2022 · Cochrane Headline outcomes onlyno estimate extracted3 studies · 1164 participantsHigh
Mepolizumab intravenous (IV) vs placeboHealth‐related quality of life (AQLQ)Scale from: 1‐7 (higher is better) · people with asthma1 finding from 1 reviewAnti‐IL‐5 therapies for asthma 2022 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 369 participantsHigh